Compare USEG & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | USEG | PDSB |
|---|---|---|
| Founded | 1966 | 2005 |
| Country | United States | United States |
| Employees | N/A | 10 |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5M | 45.2M |
| IPO Year | 1995 | 2015 |
| Metric | USEG | PDSB |
|---|---|---|
| Price | $1.15 | $0.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $3.50 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 4.9M | 445.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.00 | ★ 25.90 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $32,379,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $57.52 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.91 | $0.60 |
| 52 Week High | $2.75 | $1.90 |
| Indicator | USEG | PDSB |
|---|---|---|
| Relative Strength Index (RSI) | 54.26 | 40.75 |
| Support Level | $1.12 | $0.60 |
| Resistance Level | $1.29 | $1.16 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 34.21 | 50.64 |
US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.